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Introduction {#sec1}
============

Pluripotency is a transient state established during mammalian preimplantation development, and is characterized by the capacity to give rise to all fetal lineages. The pluripotent state can be propagated indefinitely through derivation of embryonic stem cells (ESCs) or via reprogramming strategies ([@bib7]). Mouse ESCs are considered to exhibit naive pluripotency, which reflects their ability to contribute to all embryonic lineages upon re-introduction into a blastocyst, as well as other key hallmarks such as a derestricted epigenome and two active X chromosomes in female cells ([@bib14]). The preservation of naive pluripotency in ESCs is underpinned by expression of a network of auto-regulatory transcription factors, including *Oct4, Sox2, Nanog,* and *Tfcp2l1,* which are themselves sustained by extrinsic signaling cues ([@bib8]). An alternative, and possibly more developmentally advanced state of pluripotency, can also be propagated, as exemplified by epiblast stem cells (EpiSCs) and human ESCs (hESCs) in conventional culture conditions. These are typically classified as being in a *primed* pluripotent state that is poised to initiate lineage decisions ([@bib29]).

A broader array of pluripotent states is, however, likely. For example, culture using inhibitors of MAPK signaling and GSK3β (termed 2i) together with LIF (2i/L), render mouse ESCs in a relatively uniform naive state that is molecularly and epigenetically distinct from ESCs in conventional serum/LIF medium ([@bib49], [@bib26], [@bib23]). Any two of the 2i/L components in various combinations also yield naive ESCs, which may occupy distinct phases of pluripotency ([@bib43]). Multiple other pluripotent conformations could also arise depending on the derivation strategy, available metabolites, and the precise signaling regime supplied, which may reflect distinct spatial or temporal identities ([@bib1], [@bib37], [@bib45], [@bib19], [@bib20], [@bib42]). Collectively, this suggests that a naive/primed duality model may not capture the broad complexity of pluripotency in vitro and possibly in vivo. Instead a graded spectrum of pluripotent states may emerge that exhibit distinct molecular and functional properties ([@bib14], [@bib44]).

Heterogeneity in pluripotent stem cell populations is also prevalent, in part driven by dynamic sub-states. ESCs in conventional serum/LIF conditions interconvert between several configurations that include naive and primed sub-populations ([@bib38], [@bib21]). Naive ESCs cultured in 2i/LIF are also apparently composed of sub-populations ([@bib22], [@bib27]), while EpiSCs and hESCs are also known to be highly heterogeneous ([@bib4]). This implies that dynamic heterogeneity may be a fundamental feature of pluripotent stem cells. Indeed, mouse ESCs continually transit through a *Zscan4*^*+*^ sub-state that promotes transient DNA demethylation and telomere rejuvenation, with the latter being essential for sustained pluripotent viability ([@bib50], [@bib9]). Passing through sub-states can therefore imprint a significant memory, implying that the prevalence of sub-populations could have broad functional implications for the whole ESC population.

It has recently emerged that successive stages of early mammalian development are linked with expression of distinct classes of transposable element (TE) ([@bib11]). For example, MERVL elements and their cognate MT2 LTR become active specifically at the 2-cell (2C) stage in mice, while HERVK is active from the 8-cell stage in human embryos ([@bib51], [@bib12]). These elements can significantly influence expression of nearby genes. For example, TE can act as co-opted promoters that splice to downstream genes thereby generating "chimeric transcripts" ([@bib25]). In addition, TEs can affect gene expression through promoting open chromatin configurations, production of long noncoding RNAs (lncRNA), or by acting as enhancers ([@bib36]). The impact of TEs may be particularly prevalent in pluripotent cells, since TEs are under selective pressure to be active in pluripotent or germline phases in order to propagate transgenerationally ([@bib3]). Indeed, HERVH elements have a key role in contributing to the pluripotency network in hESCs ([@bib41]). Thus, TEs represent a relatively unexplored regulatory source for the establishment and control of alternate pluripotent states.

Here, we identify a spectrum of ESC states and characterize the distinct transcriptional networks and epigenome at each node. Distinct classes of TEs are active between pluripotent conformations and influence the emergent transcriptome. Strikingly, some naive culture conditions license dynamic activation of master regulators for a specific primary germ layer (endoderm or ectoderm) or primordial germ cells (PGCs). Mechanistically, we identify *Klf4* and LIF/STAT3 as the key regulators of a *Blimp1*^*+*^ PGC-like ESC state. Overall we report that ESC populations can occupy a continuum of transcriptional states, in part through accessing sub-states under certain culture parameters.

Results {#sec2}
=======

Distinct Transcriptional States of Pluripotency {#sec2.1}
-----------------------------------------------

We initially sought to define the transcriptional variation across a broad range of pluripotent ESC states, with the expectation that any underlying differences may influence differentiation, particularly toward PGC fate. We selected nine culture parameters capable of supporting naive pluripotency, as judged by chimera contribution, and transited male (XY) low-passage (\<p13) 129X1/SvJ (129) or C57BL/6J (B6) ESCs into each condition for ≥5 passages. The culture parameters were designed to test the influence of multiple extrinsic factors including combinations of GSK3β inhibition/WNT activation (CHIR99021, hereafter Ch), MEK inhibition (PD0325901, hereafter Pd), STAT3 activity (LIF), BMP/undefined signaling (serum), vitamin C/undefined signaling (knockout serum replacement, hereafter KSR), basal medium, feeders, and genetic background, on the overall state of pluripotency ([Figure 1](#fig1){ref-type="fig"}A). We observed no overt karyotype alterations during transition to each condition, as judged by indicator chromosomes ([Figure S1](#mmc1){ref-type="supplementary-material"}A; [@bib6]).Figure 1A Transcriptional Spectrum of Pluripotent States(A) ESC culture conditions assayed in this study.(B) Heatmap showing expression of key pluripotency genes by RNA-seq.(C) Global transcriptional correlation between all genetic backgrounds and culture parameters.(D) Principal-component analysis (PCA) showing the relationship between pluripotent ESC states.(E) Loadings for PCA from (D) showing representative highly weighted genes that drive separation along each component. The histogram shows the distribution of all gene weightings.(F) PCA analysis showing in vivo pluripotent stages and the full ESC spectrum (left) or defined ESC states separated by genetic background (right).(G) Fluorescence-activated cell sorting (FACS) plot showing the response of *Stella-*GFP and *MERVL*-tdTomato (2C) ESCs in 2i/L to serum.

RNA sequencing (RNA-seq) revealed that ESCs in each condition expressed high levels of key pluripotency genes *Oct4, Sox2*, and *Nanog,* supporting their pluripotent status ([Figure 1](#fig1){ref-type="fig"}B). Some naive pluripotency genes varied among culture parameters, however, presumably reflecting the presence or absence of their direct signaling regulators. For example, *Klf4* is downregulated in 2i conditions that lack LIF, consistent with *Klf4* being a direct LIF/STAT3 target ([@bib17]), while *Tfcp2l1* is repressed in Pd/L, likely owing to attenuated WNT transduction ([@bib47]). Pluripotent markers *Stella* and *Rex1* primarily exhibited reciprocal background-dependent expression; with *Rex1* elevated in 129 ESCs and *Stella* upregulated in B6 ESCs ([Figure 1](#fig1){ref-type="fig"}B). In general, ESCs in conventional serum/LIF (S/L) conditions expressed lower overall levels of naive markers, particularly when feeder free. Thus, while the broad network of naive pluripotency genes is comparable among ESC conditions, the precise transcriptional levels of each component vary downstream of culture parameters and genetic background.

The correlation of global gene expression patterns revealed two broad clusters; a response to combinations of 2i/L components, or ESCs under S/L and Pd/L conditions ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}B). We found 3,048 genes exhibited robust differential expression (Log2(FC) \> 2; adjusted p \< 0.01) in pairwise comparisons between all states, and these assembled into distinct co-expression clusters associated with specific gene ontologies ([Figure S1](#mmc1){ref-type="supplementary-material"}C). In addition, 136 and 82 genes are robustly linked with 129- or B6-specific expression, respectively, which we confirmed using multiple independent 129 and B6 ESC lines ([Figure S2](#mmc1){ref-type="supplementary-material"}A).

To further investigate the relationship between each pluripotent condition we applied principal-component analysis (PCA). Strikingly, we observed a clear separation of ESC states along the first component (PC1) that appeared to reflect an ordering of developmental progression; ranging from 2i/L (with or without serum/KSR) through to feeder-free S/L ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}D). By contrast PC2 separated ESCs according to genetic background (129 versus B6), while PC3 apparently segregated ESCs cultured in the presence or absence of serum/KSR, irrespective of other signaling influences ([Figure 1](#fig1){ref-type="fig"}D). To validate these interpretations, we examined the gene loadings along each principal component to determine the key driver genes that separate ESC states. Notably, negative PC1 values were strongly weighted by naive-associated genes, and in particular *Tfcp2l1* and *Prdm14.* In contrast, positive PC1 scores were driven by primed and early developmental genes including *Fgf5, Otx2*, and *Lefty1* ([Figure 1](#fig1){ref-type="fig"}E). This is consistent with separation along PC1 reflecting a spectrum of pluripotent ESC states that range from most naive to most developmentally progressed, with conditions such as Ch/L establishing intermediary states of naive pluripotency.

To investigate how this apparent pluripotent spectrum relates to embryonic ontogeny, we compared the ESC transcriptomes with publically available in vivo developmental stages ([@bib2]). The first component here reflected technical differences but the analysis still recapitulated the continuum of ESC states, and, strikingly, they broadly correspond to developmental progression of the pluripotent epiblast lineage ([Figure 1](#fig1){ref-type="fig"}F). Specifically, the most naive ESC states cluster closest with embryonic day 3.5 (E3.5) inner cell mass, whereas ESC states predicted to be further along the pluripotent spectrum become progressively more comparable with E4.5 and, to some degree, E5.5 epiblasts ([Figure 1](#fig1){ref-type="fig"}F).

We next examined the other principal components that separate ESC states and observed that gene loading along PC2, which delineates genetic background, exhibited no significant gene class enrichment, albeit some neuroectodermal genes such as *Olig1* are linked with B6 ESCs ([Figure 1](#fig1){ref-type="fig"}E). This implies that, although background has significant influence on the precise ESC transcriptome, no specific gene category predominates. Finally, gene loadings for PC3 revealed strong weighting for BMP targets *Id1* and *Id2*, along with mesendoderm genes, consistent with separation of ESC transcriptomes according to the presence of BMP-rich serum or KSR. However notably, the most significant PC3 weightings (nine out of ten top genes) correspond to genes preferentially expressed in 2-cell embryos, including *Zscan4* and *Tcstv3,* suggesting the 2C program is the single most affected pathway downstream of serum/KSR supplementation ([Figure 1](#fig1){ref-type="fig"}E).

To further investigate this and to test the PCA predictions we generated ESCs carrying dual reporters for 2C gene activity and *Stella,* which are expected to respond reciprocally to serum (see PC3) ([Figure 1](#fig1){ref-type="fig"}E). Consistently, we found that addition of serum to 2i/L reduced the fraction of *Stella-*positive ESCs by 4.0-fold, while concurrently increasing the fraction of 2C-positive ESCs by 3.7-fold ([Figures 1](#fig1){ref-type="fig"}G and [S1](#mmc1){ref-type="supplementary-material"}E). In summary, we identify a spectrum of multiple naive pluripotent states that emerge in response to distinct combinations of extrinsic signaling cues. This spectrum appears to correspond to a developmental progression of pluripotency. The emergent ESC states are further dispersed depending on genetic background and/or additional supplements, such as serum or KSR. Moreover, the spectrum may in part reflect different sub-population identities and frequencies between culture parameters, as exemplified by 2C and *Stella*-positive ESCs.

Retrotransposon Activation Is Linked with Pluripotent State {#sec2.2}
-----------------------------------------------------------

Stage-specific activation of distinct TEs has been observed during successive stages of early embryonic development ([@bib11]). To investigate whether each state along the ESC pluripotent spectrum is also linked with a specific signature of TE activity, we examined differentially expressed repeat families. We found 64 significantly altered families (total n = 1,110) in pairwise comparisons, of which 51 belonged to the LTR class of retrotransposons, including MERVL, MT2, and IAPLTR3 ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}B). Several TE families are preferentially active in a specific ESC condition, for example LTR9 and L1M3d in Ch/L and S/L_F, respectively. Interestingly, PCA analysis of TE expression ordered the samples into a highly comparable arrangement as gene-based PCA, apparently recapitulating the pluripotent continuum ([Figure 2](#fig2){ref-type="fig"}B).Figure 2Transposable Element Activation across the Pluripotent Spectrum(A) Relative proportion of differentially expressed transposable element (TE) families between pairwise comparisons of all conditions.(B) PCA showing the relationship between pluripotent states based on differential TE activation.(C) Expression of selected LTR and LINE elements across the pluripotent continuum.(D) Expression of the lncRNA *Miat*.(E--G) Genome view showing RNA-seq tracks of detected chimeric transcripts that originate at an upstream LTR and splice to (E) *Tcstv3*, (F) *Cyp2b23*, and (G) *Ash2l*.(H) Boxplots showing the median global DNA methylation (5-mC) level by bisulfite sequencing across various genomic features in the indicated culture condition and genetic background.(I) Heatmap showing DNA methylation level at genomic imprints.

Examining loading of retrotransposons in the PCA revealed that families including IAPEy-int and RLTR45 strongly weighted the most naive-like ESC states (2i/L, 2i), whereas higher expression of MER50B and the LINE family L1M6B was linked with more developmentally progressed pluripotent identities ([Figure 2](#fig2){ref-type="fig"}C). The strong weighting of IAPEy-int is noteworthy as this family shares closest homology with HERVK elements, which are implicated in influencing human pluripotent cells ([@bib12]). We additionally found 70 differentially expressed lncRNA between ESC conformations, many of which originate at TEs ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Among these the lncRNA *Miat,* which is involved in a feedback loop with pluripotency-associated factors ([@bib34]), is progressively upregulated in each pluripotent state along the spectrum ([Figure 2](#fig2){ref-type="fig"}D).

Next, we asked whether activation of distinct sets of TE is directly linked with altered gene expression. We initially noted that between defined conditions (serum-free), 2i ESCs preferentially activated MT2 and MERVL elements, as well as many 2C-associated genes that can derive from such repeats as chimeric transcripts. Among these, expression of the telomere regulators *Tcstv3* and *Zscan4*, and the metabolism gene *Arg2*, is highly elevated in 2i. Analyzing spliced RNA-seq reads revealed that gene upregulation in 2i is often a direct consequence of activation of upstream MERVL and MT2 elements, which initiate chimeric transcripts ([Figure 2](#fig2){ref-type="fig"}E).

Using our RNA-seq datasets to detect additional spliced junctions, we identified a further 637 chimeric transcripts across the pluripotent conditions, which derive from activated TEs upstream of the first annotated exon. Many of these are active or repressed in only a subset of pluripotent states. For example an LTRIS2 element upstream of *Phf11d* is responsible for a chimeric transcript, but this TE is preferentially repressed in Pd/L ESCs. As a consequence *Phf11d* mRNA is significantly downregulated in the Pd/L pluripotent conformation ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Similarly, activation of adjacent EtnERV2, RMER16, and PD1D10 elements upon KSR addition drives strong expression of the downstream *Cyp2b23* gene (\>30-fold transcriptional upregulation) specifically in 2i/L_K ESCs ([Figure 2](#fig2){ref-type="fig"}F). The potential significance of such TE-based regulatory mechanisms is underscored by our observation that a chimeric transcript derived from an RLTR12C element drives primary expression of the essential pluripotency gene *Ash2l* in ESCs ([@bib52]; [Figure 2](#fig2){ref-type="fig"}G). Other key genes including *Grb2* and *Zfp640* also appear to be at least partly expressed from an upstream TE (data not shown). Taken together our data imply that each state of naive pluripotency is associated with a distinct repertoire of transcriptionally active retrotransposons, particularly among the LTR class. In some cases this is directly responsible for modulating gene transcription through chimeric transcripts. Notably, this links altered retrotransposon activity and overall ESC state.

DNA Methylation across the Pluripotent Spectrum {#sec2.3}
-----------------------------------------------

Global DNA hypomethylation is intimately associated with naive pluripotency, whereas increasing DNA methylation (5-methylcytosine, 5-mC) levels are generally linked with primed pluripotency and lineage commitment ([@bib23]). We used shallow-coverage whole-genome bisulfite sequencing to investigate 5-mC across the pluripotent spectrum. Genome-wide 5-mC levels were lowest in 2i/L (18%--37%) and most elevated in S/L_KD (78%--83%) ESCs, consistent with previous reports ([@bib13], [@bib10], [@bib15]). However rather than falling into binary hypo- or hypermethylated status, other pluripotent states exhibited a gradient of progressive global 5-mC, with Pd/L (53%--61%) and Ch/L (69%--75%) associated with intermediate DNA methylation levels, for example ([Figure 2](#fig2){ref-type="fig"}H). Thus, similar to the continuum of transcriptional states, ESCs acquire a spectrum of epigenetic states.

The trend of DNA methylation was preserved across distinct genomic features such as promoters, enhancers, and repetitive elements ([Figures 2](#fig2){ref-type="fig"}H and [S3](#mmc1){ref-type="supplementary-material"}B). An exception, however, is genomic imprints. These were relatively stable across most conditions (particularly in 129 background), but exhibited atrophy in 2i/L and erasure in 2i/L+KSR culture ([Figure 2](#fig2){ref-type="fig"}I). This latter observation may reflect the presence of vitamin C in KSR, which directly enhances TET activity, previously linked with erasure of imprints ([@bib46], [@bib16], [@bib1], [@bib32]). In summary, the 5-mC epigenome is established across a wide spectrum in ESCs, ranging from hypo- to hypermethylated, with the precise level correlated to the developmental progression of the underlying pluripotent transcriptome and, to some extent, the presence of MEK inhibitor (Pd). The transcriptional level of genes known to influence DNA methylation levels, such as *Dnmt3a, Uhrf1, Tet1*, and *Prdm14,* did not definitively correlate with global 5-mC levels, however ([Figure S3](#mmc1){ref-type="supplementary-material"}C). This may indicate that the overall epigenetic state in ESCs is regulated by a complex interplay between gene expression, available metabolites, and post-transcriptional control, such as recently shown for UHRF1 ([@bib39]).

Naive ESC Populations Exhibit Lineage-Associated Co-activation {#sec2.4}
--------------------------------------------------------------

To investigate the pluripotent spectrum in more detail, we selected four defined (serum-free) conditions (2i/L, 2i, Ch/L, and Pd/L) associated with a clear naive signature and robust chimera contribution ([@bib8]). We confirmed naive status by using the ΔPE *Oct4*-GFP reporter, which marks activation of the naive-specific distal *Oct4* enhancer in ESCs. All states exhibited a single peak of GFP, implying relatively uniform naiveté among these populations ([Figure 3](#fig3){ref-type="fig"}A). To examine any underlying molecular differences between the naive states, we identified 1,056 differentially expressed genes (Log2(FC) \> 2; p \< 0.01) in all pairwise comparisons. These genes were primarily linked with differential metabolic processes, but surprisingly also included several markers of alternate lineage fates. Indeed, gene ontology analysis of genes upregulated uniquely in only one condition suggested activation of divergent germ layer programs, such as neurogenesis-related processes in Pd/L ([Figure 3](#fig3){ref-type="fig"}B).Figure 3Distinct Naive ESC Conditions Activate Master Lineage Regulators(A) FACS analysis showing near-uniform activation of the ΔPE *Oct4*-GFP naive pluripotency reporter in ESCs under defined conditions.(B) Heatmap of differentially expressed genes in pairwise comparisons between naive ESC states. Selected genes from pathways enriched by gene ontology are shown.(C) Heatmap showing expression of master regulator genes for each of the three primary germ layers and the germline (PGC).(D) Immunofluorescence staining for master regulators of the germline (BLIMP1), endoderm (SOX17), and neuroectoderm (PAX6) in defined ESC conditions. Scale bars, 50 μm.(E) FACS plots showing *Sox1-*GFP activation upon neural induction from indicated ESC conditions.(F) qRT-PCR showing expression of indicated genes in ΔPE *Oct4*-GFP ESCs and upon induction of epiblast-like cells (EpiLCs) for 2 days. n = 3 biological replicates each assayed in technical triplicate; error bars, SEM.(G) Representative examples of primordial germ cell (PGC)-like cell (PGCLC) induction from ancestral ESC conditions. Shown is the percentage of PGCLCs as determined by FACS. Scale bars, 200 μm.

To explore this further we inspected expression of master regulators for the three primary germ layers; endoderm, mesoderm, and ectoderm, as well as the germline, among the four naive states. Remarkably, we found that pluripotent ESCs in Pd/L strongly and specifically co-expressed multiple master (neuro)ectoderm genes such as *Sox1, Pax6*, and *NeuroD1*, but not markers of other lineages, in both 129 and B6 backgrounds ([Figure 3](#fig3){ref-type="fig"}C). By contrast, Ch/L ESCs upregulated master regulators for endoderm specification including *Sox17, Gata4*, and *Gata6,* as well as definitive endoderm markers *FoxA2* and *Hnf1b.* Finally, 2i conditions exhibited a clear PGC signature, uniquely co-activating the three key PGC specification genes *Blimp1, Prdm14*, and *Ap2γ*, and some primitive streak/mesodermal genes such as *Mixl1*. Unsupervised hierarchical clustering further revealed that 2i, Ch/L, and Pd/L each segregate separately from all other pluripotent conditions based only on expression of germline, endoderm, and neuroectoderm master regulators, respectively ([Figure S4](#mmc1){ref-type="supplementary-material"}A). This highlights their exclusive overall state with respect to lineage-associated expression. Notably, however, master primary germ layer genes were near undetectable in 2i/L ESCs ([Figure 3](#fig3){ref-type="fig"}C).

We next sought confirmation for activation at the protein level by immunostaining. This revealed robust detection of the key germline-determinant BLIMP1 in 2i, endoderm regulators SOX17 and GATA4 in Ch/L, and neuroectoderm regulators PAX6 and OTX2 in Pd/L, but near-undetectable levels in reciprocal conditions ([Figures 3](#fig3){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}B). NANOG was strongly detected under all parameters. In general, lineage-associated expression was heterogeneous, possibly reflecting dynamic expression. Using the Fucci reporter, we also noted altered cell-cycle dynamics between pluripotent states, which can influence lineage-bias in stem cells (data not shown) ([@bib31]). Overall, the tested pluripotent parameters appear to differentially license activation of lineage-specific master regulators, with a subset of ESCs shuttling into positive state.

To investigate whether lineage-associated expression influences cell fate, we seeded ESCs in N2B27 medium without cytokines, which preferentially induces neuroectoderm specification, but is also permissive for other lineages ([@bib48]). Using *Sox1*-GFP ESCs that report on acquisition of neuroectoderm fate, we observed that cells from the ancestral Pd/L condition activated GFP both earlier and with greater maximal efficiency (\>80%) than ESCs from other initial parameters. Moreover Ch/L maintained ESCs, which exhibited some activation of endoderm regulators, were relatively resistant to acquiring a *Sox1*-GFP^+^ fate (18%--31%) ([Figure 3](#fig3){ref-type="fig"}E).

We next asked whether an alternative strategy of differentiation is also influenced by initial pluripotent state by inducing PGC fate. PGC specification proceeds through induction of naive ESCs into epiblast-like cells (EpiLCs), which closely parallel post-implantation epiblast cells, and subsequently specification of PGC-like cells (PGCLCs) in embryoids ([@bib18]). All examined ESC states formed morphologically equivalent EpiLCs, which expressed comparable levels of "primed" markers such as *Fgf5* and *Dnmt3b*, while concurrently repressing naive genes including *Nanog* and *Klf4* ([Figures 3](#fig3){ref-type="fig"}F, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B). The differential expression of most lineage regulators also equalized during EpiLC induction. Nonetheless, we observed a marked difference in PGCLC specification from EpiLCs depending on the predecessor condition of ESCs.

Specifically, PGCLCs were specified with high efficiency from ancestral 2i/L ESCs and, in particular, from 2i ESCs. In contrast, PGCLC specification from initial Ch/L and Pd/L states was significantly impaired, as judged by detection of ΔPE *Oct4*-GFP and *Blimp1*-GFP ([Figures 3](#fig3){ref-type="fig"}G and [S5](#mmc1){ref-type="supplementary-material"}C). PGCLCs derived from all ESC culture parameters exhibited appropriate germline gene expression signatures, suggesting that they all acquire PGC fate, but differ in their specification efficiency ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Thus, the initial pluripotent ESC condition establishes an enduring memory that affects subsequent differentiation potential, despite an apparently normalizing intermediate EpiLC step. Collectively, these analyses imply that the initial pluripotent parameters can influence the rate and efficiency of directed differentiation toward distinct lineages. This appears to be partly correlated with the differential licensing of lineage-associated programs between ESC conditions, albeit other factors also likely contribute.

ESCs Transit through a Blimp1^+^ PGC-like State {#sec2.5}
-----------------------------------------------

We next sought to investigate the nature of lineage-associated programs in naive ESCs, focusing on the apparent germline state enriched in 2i. We employed a GFP reporter for the key PGC specifier *Blimp1*, which faithfully reports on endogenous BLIMP1 expression in ESCs ([Figure 4](#fig4){ref-type="fig"}A). While ESCs in all four naive conditions express the undifferentiated marker CD31, ESCs in 2i contained a greater proportion of *Blimp1*-GFP^+^ ([Figure 4](#fig4){ref-type="fig"}B).Figure 4ESCs Enter a *Blimp1*-Positive PGC-like State(A) Immunofluorescence staining of ESCs showing co-activation of *Blimp1*-GFP and endogenous BLIMP1. Scale bar, 50 μm.(B) FACS plots of ESCs in indicated conditions showing 2i most strongly activates *Blimp1* expression.(C) Gene expression of naive pluripotency markers (upper) and PGC markers in sorted *Blimp1*^*−*^*, Blimp1*^*low*^, and *Blimp1*^*high*^ ESC fractions by qRT-PCR. n = 3 values obtained from technical replicates; error bars, SEM.(D) FACS showing that purified *Blimp1*^*+*^ and *Blimp1*^*−*^ ESC fractions reacquire the initial equilibrium of *Blimp1*-GFP activity in the population after 4 days.(E) Capacity of single or pools of five *Blimp1*^*+*^ or *Blimp1*^*−*^ ESCs maintained in 2i/L to contribute to embryonic chimeras. ET, embryo transfers.(F) Representative images of chimera contribution at E6.5 of constitutive H2B-tdTomato ESCs from *Blimp1*^*+*^ or *Blimp1*^*−*^ fractions. Scale bars, 200 μm.(G) Alkaline phosphatase-positive colony formation by sorted *Blimp1*^*+*^ and *Blimp1*^*−*^ ESCs. Quantification of independent ESC lines in the right panel. Scale bar, 5 mm.

To determine the identity of this population we isolated *Blimp1-*high, -low, or -negative ESCs, and found that all fractions express equivalent levels of the pluripotency genes, *Oct4, Sox2*, and *Nanog*, by qRT-PCR. Strikingly however, there was a highly significant upregulation of PGC markers *Nanos3, Ap2γ, Blimp1*, and *Stella*, specifically in the *Blimp1*^+^ ESCs ([Figure 4](#fig4){ref-type="fig"}C). This was paralleled by strong repression of *Uhrf1* and *Klf4,* which are coordinately silenced uniquely in the PGC lineage. In contrast, expression of primitive endoderm genes *Gata4, Sox7*, and *Hex*, which are also associated with BLIMP1 ([@bib30]), were not altered. These data are consistent with *Blimp1*^+^ ESCs acquiring a PGC-like transcriptional conformation ([Figure S5](#mmc1){ref-type="supplementary-material"}E). We next considered that *Blimp1*^+^ ESCs could either reversibly transit between positive and negative status in culture, or represent a static population. To determine this we fluorescence-activated cell sorted and re-plated *Blimp1* -positive and -negative cells. After 4 days both isolated sub-populations reacquired equivalent levels of *Blimp1*^+^ cells, indicating that at least some ESCs can enter and exit *Blimp1*^+^ status at a frequency that rapidly leads to population equilibrium ([Figure 4](#fig4){ref-type="fig"}D).

To characterize *Blimp1*^+^ ESCs functionally, we inserted a constitutive H2B-tdTomato cassette into the *Blimp1-*GFP ESC line. We then introduced either 1-cell or 5-cells from 2i/L culture into blastocysts to examine the capacity for contribution to chimeras. Whereas *Blimp1*^*−*^ ESCs robustly integrated into chimeras (12% for 1-cell and 67% of embryos for 5-cell injections), *Blimp1*^*+*^ ESCs contributed poorly (0% for 1-cell and 7% of embryos for 5-cell injections), despite both populations expressing high levels of naive pluripotency genes ([Figures 4](#fig4){ref-type="fig"}E and 4F). We next tested colony-formation capacity and found that *Blimp1*^+^ ESCs generated significantly fewer alkaline-positive colonies after re-plating than *Blimp1*^*−*^ ESCs ([Figure 4](#fig4){ref-type="fig"}G). These results are consistent with observations that PGCs cannot contribute to chimeras or directly form colonies, despite expressing naive pluripotency genes ([@bib24]). The combined data support the conclusion that ESCs transiently acquire a PGC-like status, with the frequency elevated in 2i-only conditions.

Klf4 Regulates a Germline Configuration in ESCs {#sec2.6}
-----------------------------------------------

To understand how extrinsic signals affect dynamic ESC sub-populations we sought to investigate the regulatory principles that modulate the PGC-like ESC status. The observation that *Blimp1*^*+*^ are most prevalent in the 2i without LIF implies that LIF may repress entry into the germline program. To test this we found that inhibition of LIF targets JAK, but not phosphatidylinositol 3-kinase, restored the fraction of *Blimp1*-GFP^+^ cells in 2i/L to 2i levels, suggesting that JAK/STAT3 is the critical germline-repressive pathway downstream of LIF ([Figure 5](#fig5){ref-type="fig"}A). JAK/STAT3 is known to activate multiple direct targets in ESCs, including *Klf4, Gbx2, Tfcp2l1*, and *Klf2.* Forced expression of these factors using ESCs maintained in 2i revealed *Klf4* most strongly downregulates *Blimp1* activation to levels comparable with 2i/L ([Figure 5](#fig5){ref-type="fig"}B). Subsequent immunostaining revealed that KLF4 expression within ESC colonies is inversely correlated with BLIMP1, supporting a direct relationship ([Figure 5](#fig5){ref-type="fig"}C).Figure 5*Klf4* Represses the *Blimp1*-Positive State in ESCs Downstream of STAT3(A) Percentage of *Blimp1*^*+*^ ESCs in 2i/L with or without the JAK kinase inhibitor or the phosphatidylinositol 3-kinase (PI3K) inhibitor.(B) Percentage of *Blimp1*^*+*^ ESCs in 2i with forced expression of the indicated LIF target gene (A and B). n = 3 biological replicates each assayed in technical triplicate; error bars, SEM.(C) Immunofluorescence staining of *Blimp1*-GFP and KLF4 in ESC colonies showing mutually exclusive expression. Scale bar, 50 μm.(D) Immunofluorescence showing knockout (KO) of *Klf4* in independent ESC lines and undetectable effects on pluripotency gene NANOG. Scale bars, 50 μm.(E) qRT-PCR analysis of gene expression in *Klf4* KO ESCs. n = 3 biological replicates each assayed in technical triplicate.(F) FACS analysis showing a significant increase in the *Blimp1*^*+*^ fraction in *Klf4* KO ESCs.(G) Western blot showing KLF4 transgene rescue to WT-equivalent levels (−) or overexpression (+) in *Klf4* KO cells.(H) Re-expressing KLF4 re-imposes repression of the *Blimp1*^*+*^ ESC state in a dose-dependent manner. n = 3 biological replicates each assayed in technical triplicate; error bars, SEM.

To investigate this possibility we generated *Klf4*^*−/−*^ ESCs carrying *Blimp1-*GFP using CRISPR targeting. Mutant ESCs formed colonies, proliferated normally, and maintained strong expression of NANOG ([Figure 5](#fig5){ref-type="fig"}D). Moreover, qRT-PCR profiling showed that expression of naive markers was unaltered between wild-type (WT) and *Klf4*^*−/−*^ ESCs, with the exception of modest upregulation of *Klf2* ([Figure 5](#fig5){ref-type="fig"}E). Importantly, in the absence of *Klf4*, activation of *Blimp1-*GFP in 2i/L increased markedly to levels similar to 2i, suggesting that KLF4 is the critical mediator sufficient to drive LIF-dependent repression of the PGC program in ESCs ([Figure 5](#fig5){ref-type="fig"}F). To examine whether re-introduction of *Klf4* rescued this, we made use of a destabilized *Klf4* construct whereby exogenous KLF4 is stabilized by addition of *Shield1,* enabling tuning of protein levels. In the absence of *Shield1*, the levels of exogenous KLF4 reached levels comparable with WT, while addition of *Shield1* led to a significant overexpression ([Figure 5](#fig5){ref-type="fig"}G). We found that expressing *Klf4* at WT levels in knockout ESCs re-imposed repression of the *Blimp1*^*+*^ PGC-like state in 2i/L. Moreover, elevating KLF4 levels further by addition of *Shield1* further reduced the fraction of *Blimp1*^*+*^ ESCs to \<0.5% ([Figure 5](#fig5){ref-type="fig"}H), with KLF4 chromatin immunoprecipitation-qPCR of the *Blimp1* promoter suggesting that this may be an indirect effect ([Figure S5](#mmc1){ref-type="supplementary-material"}G). Thus, *Klf4* acts downstream of LIF/STAT3 signaling in ESCs to block dynamic entry into a germline-associated configuration.

Discussion {#sec3}
==========

Our study reports a spectrum of distinct transcriptional states of pluripotency that appear to order from most naive associated to most developmentally advanced. The spectrum reflects a response to culture conditions, which influence the overall ESC transcriptome and epigenome, as well as controlling access to sub-populations. The continuum of ESC states is coupled with a gradient of increasing global DNA methylation levels, with the more hypomethylated states most closely linked with a naive signature. Moreover, alternate pluripotent conformations are linked with activation of at least some distinct classes of TEs. This, in turn, appears to influence the transcriptome, potentially through a number of routes, such as opening local chromatin structure, acting as enhancers, or forming chimeric transcripts ([@bib5]). We observed that the latter mechanism is prevalent, with chimeric transcript expression often being restricted to a unique or subsets of pluripotent conditions.

Stage-specific activation of TEs has been observed during early embryonic development, and is thought to have been co-opted to drive gene regulatory networks in a stepwise manner ([@bib36]). In this way, sequential TE activation may coordinately regulate groups of genes required for successive stages of ontogeny. An example of this can be seen at the 2C embryonic stage, where multiple key genes are activated as chimeric transcripts from MT2 and MERVL elements ([@bib25]). The observation that the distinct ESC conformations observed here are also linked with differential TE activity suggests that TEs may contribute to overall pluripotent status. Notably it is possible that the gradient of epigenomic states across conditions partially underpins differential TE expression, as TEs are generally more prominently activated in hypomethylated ESCs here, and transition between pluripotent/epigenetic states is also linked with distinct TE responses ([@bib40]). Moreover, repeat elements activated in the more derestricted epigenetic states along the spectrum, such as LTR45 and IAP, correlate well with TEs activated upon deletion of epigenetic regulators ([@bib33]). This collectively implies a direct relationship between the epigenome, TE activity, and overall cell state.

Whether alternate in vitro pluripotent states have any functional significance is an important question. Indeed, despite inducing broad transcriptional/epigenetic differences, the assayed culture conditions are still all capable of supporting naive pluripotency, implying that activation of the core pluripotency network overcomes wider gene expression variance. Nevertheless, the initial naive condition may subtly influence subsequent differentiation efficiency. For example, ESC propagation in Pd/L led to a poor capacity to generate the germline in vitro, but by contrast was highly efficient for the induction of nascent neuroectoderm. Likewise, culture in 2i without LIF supported high PGCLC induction, whereas Ch/L impaired such specification. It may, therefore, be important to consider the initial ESC culture condition when optimizing directed differentiation approaches, as it can leave a legacy that influences subsequent cell fate efficiency. This would imply that there is no optimal pluripotent condition to induce every cell fate with maximal efficiency, but rather a certain degree of pre-existing "bias" might be exploited according to the required endpoint. Indeed, this has recently been demonstrated by utilizing naive-like hESCs that modestly co-express primitive streak/mesodermal regulators to directly generate human PGCLCs with high efficiency ([@bib20]). A further issue to consider is the apparent atrophy of imprints after extended 2i/L culture, which would be predicted to impact the developmental potential of ESCs.

A key contributor to the distinct transcriptomes between culture conditions is differential heterogeneity, as revealed at the protein level. This extends to master lineage regulators such as SOX17, GATA4, PAX6, OTX2, SOX1, and BLIMP1. Using *Blimp1*^*+*^ cells as a paradigm, we observed that this heterogeneity is transient, and marks a sub-population of ESCs in naive conditions with PGC-like properties. This includes strong upregulation of important germline markers *Stella, Nanos3, Ap2y*, and *Blimp1*, downregulation of *Uhrf1* and *Klf4,* and poor performance in pluripotency assays despite strong expression of core pluripotency genes, which are all consistent with PGC properties. We show that activation of the PGC-like state in ESCs is directly repressed by LIF/STAT3 signaling. The critical LIF/STAT3 target is *Klf4*, which unlike other naive pluripotency genes, is repressed in PGCs in vivo ([@bib28]), presumably to enable activation of the incipient germline program. Activation of *Blimp1* in ESCs may be a consequence of the negative feedback loop that operates on LIF/STAT3 signaling ([@bib35]), which would promote windows of *Klf4* downregulation and transient activation of a PGC-like program. The prevalence of such cell-state dynamics in ESC populations may leave an enduring molecular memory, perhaps by enhancer priming, which influences subsequent cell responses to inductive cues. Alternatively, differences between culture conditions may reflect other parameters, such as differential metabolic profiles or chromatin states. The extent to which these possibilities are responsible for defining ESC states and responses merits further investigation.

Experimental Procedures {#sec4}
=======================

All husbandry and experiments involving mice were authorized by a UK Home Office Project License 80/2637 and carried out in a Home Office-designated facility.

ESCs were maintained on gelatin-coated dishes using culture medium as specified in [Figure 1](#fig1){ref-type="fig"}A, for at least five passages prior to experimental analysis. ESCs were maintained in a humidified 37°C chamber supplemented with 5% CO~2~ and passaged every 2--3 days with TrpLE. RNA-seq was performed on independent replicate samples using the TruSeq RNA Library Preparation v. 2.0 Kit (Illumina). Whole-genome bisulfite sequencing was carried out using the EZ DNA Methylation Gold Kit (Zymo Research) and Ovation Ultralow Methyl-seq Kit (NuGEN). Libraries were sequenced on a HiSeq 1500 or 2500. Differentiation assays were performed as described previously ([@bib48], [@bib18]). CRISPR-mediated knockout of *Klf4* was achieved using dual gRNAs and the Cas9 nickase to target a critical portion of exon 3. A complete description of all methods and bioinformatics analysis is listed in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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